Pfizer

By Heather Mack July 20, 2016
Digital medicine company Akili Interactive Labs announced an $11.9 million expansion of its recent Series B funding, adding new investors into the round and bringing the series total to $42.4 million. The Dutch subsidiary of Merck Ventures, known as M Ventures in the US and Canada, and the venture arm of Amgen joined existing investors, which include Pfizer and Shire Pharmaceuticals. This means...
By Jonah Comstock July 6, 2016
Correction: A previous version of this article contained inaccuracies based on an out-of-date version of the research proposal.  Pfizer is working with Brigham and Women's Hospital in Boston to test an app for rheumatoid arthritis in a small clinical trial, according to a ClinicalTrials.gov posting. One hundred and ninety patients will be enrolled in the trial, which is set to conclude in...
By MHN Staff April 8, 2016
More and more, pharma companies are making real bets in digital health, and reorganizing their businesses to put some power behind those efforts. The space is, in some ways, quieter than it was this time last year, but there’s reason to believe that quiet is a calm before a storm of activity, driven more by pharma’s tendency to keep early-stage projects close to the chest than by a lack of...
By Aditi Pai April 7, 2016
Pfizer has partnered with IBM to develop a system that clinicians can use to treat patients who have Parkinson’s disease. The system will make use of sensors, mobile devices, and machine learning to provide clinicians and researchers with symptom information, which they will then use to better understand patient disease progression and medication response. It will also help inform treatment...
By Aditi Pai February 15, 2016
Pfizer Consumer Healthcare, a division of Pfizer that maintains consumer health brands including Advil, Caltrate, Centrum, ChapStick, and Nexium24 HR, has partnered with education company Galvanize to launch a health tech accelerator. The six month program will launch in early March at Galvanize’s San Francisco office. Pfizer and Galvanize plan to accept ten companies focused on improving sleep,...
By Jonah Comstock November 9, 2015
NYC-based pharma company Pfizer currently has 15 apps in the US iOS app store, ranging from a chapstick companion app to an app for people with kidney cancer. At the HIMSS Connected Health Summit in National Harbor, Maryland, Pfizer executives talked about two of the company's apps and their broader strategy for developing mobile health interventions. "We recognize that the data shows patients...
By Jonah Comstock July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular. Last week the...
By Jonah Comstock July 6, 2015
According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million. The investors are undisclosed and 23andMe declined to comment while the round was ongoing. This is the company's largest single funding raise to date. It brings its total funding to $190 million plus a $1.4 million research...
By Jonah Comstock June 17, 2015
Pfizer Head of Clinical Innovation Craig Lipset In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail. But that trial was cancelled due to a failure to recruit enough participants, and a promised mulligan never emerged. Craig Lipset, Pfizer's Head of Clinical Innovation, said at the...
By Aditi Pai April 30, 2015
A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians. The survey was conducted by Ipsos in collaboration with the National Council on Patient Information and Education (NCPIE) and Pfizer. The survey found that 64 percent of respondents said they could be making more decisions about their health and...